QFVinardo docking also identified NICLOSAMIDE as the 4th strongest binding drug for the 6LU7 target, with the same low-energy conformation having 0.061 kcal/mol conformational strain energy and a total binding energy of -6.54 kcal/mol. Regarding the other target, QFVina identified GILTERITINIB as the 21st strongest binding drug for the 6Y2G target, with its lowest energy conformation and an overall binding energy of -9.997 kcal/mol. QFVina also identified ELTROMBOPAG as the 5th strongest binding drug for the 7BZ5 target, with its lowest energy conformation and an overall binding energy of -10.289 kcal/mol. QFVinardo further improved the ranking for ELTROMBOPAG, identifying it as the 2nd strongest binding drug for the 7BZ5 target, with an estimated binding energy of -7.955 kcal/mol. Finally, QFVinardo identified IVACAFTOR as the 36th strongest binding drug for the 6Y2G target.